Medico-economic Interest of the Protein S100b in Mild Head Trauma Under Anti-thrombotics

CompletedOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

March 9, 2020

Primary Completion Date

September 20, 2021

Study Completion Date

September 20, 2021

Conditions
Mild Head InjuryAnticoagulantAntiplatelet
Interventions
OTHER

Dosage of S100β protein

Dosage of S100β protein

Trial Locations (1)

35000

Centre Hospitalier Universitaire de Rennes, Rennes

All Listed Sponsors
collaborator

Roche Diagnostics GmbH

INDUSTRY

lead

Rennes University Hospital

OTHER

NCT04305821 - Medico-economic Interest of the Protein S100b in Mild Head Trauma Under Anti-thrombotics | Biotech Hunter | Biotech Hunter